ASRT vs CUBE
Assertio Therapeutics Inc (ASRT) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
ASRT currently screens at market cap $151.5M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the ASRT and CUBE stock pages for the full models.
Not investment advice.